Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
57,963 | 102,695 | 2,123 | 1,927 | 77,903 |
Depreciation & Amortization Expense |
NA | 260 | 190 | 160 | 115 |
SG&A Expense |
16,667 | 23,680 | 19,415 | 19,729 | 15,905 |
Research & Development |
10,261 | 19,072 | 15,385 | 15,828 | 12,076 |
Other SG&A |
6,406 | 4,608 | 4,030 | 3,901 | 3,829 |
Other Operating Expense |
NA | 0 | 0 | 0 | 0 |
Unusual Expense |
NA | 0 | 0 | 0 | 0 |
Non Operating Income/Expense |
NA | -1 | -2 | -5 | -12 |
Equity in Affiliates (Pretax) |
NA | 0 | 0 | 0 | 0 |
Interest Expense |
NA | 0 | 0 | 0 | 0 |
Gross Interest Expense |
NA | 0 | 0 | 0 | 0 |
Pretax Income |
41,373 | 78,807 | -17,435 | -17,906 | 61,904 |
Income Tax |
-554 | 3,201 | -529 | -5,083 | 5,651 |
Equity in Affiliates |
NA | 0 | 0 | 0 | 0 |
Consolidated Net Income |
41,927 | 75,606 | -16,906 | -12,823 | 56,253 |
Minority Interest Expense |
NA | 0 | 0 | 0 | 0 |
Net Income |
41,927 | 75,606 | -16,906 | -12,823 | 56,253 |
Extraordinaries & Discontinued Operations |
NA | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
NA | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
NA | 0 | 0 | 0 | 0 |
Discontinued Operations |
NA | 0 | 0 | 0 | 0 |
Net Income After Extraordinaries |
75,606 | -16,906 | -12,823 | 56,253 | |
Preferred Dividends |
NA | 0 | 0 | 0 | 0 |
Net Income available to Common |
41,927 | 75,606 | -16,906 | -12,823 | 56,253 |
Operational EPS |
0.56 | 1.02 | -0.23 | -0.19 | 0.78 |
EPS (basic) |
0.60 | 1.09 | -0.25 | -0.19 | 0.82 |
EBITDA |
NA | 79,015 | -17,292 | -17,802 | 61,998 |
Depreciation & Amortization Expense |
NA | 260 | 190 | 160 | 115 |
Common Shares Outstanding |
NA | 74,456 | 72,617 | 68,848 | 71,725 |
Basic Shares Outstanding |
69,839 | 69,512 | 68,728 | 68,848 | 68,658 |
Diluted Shares Outstanding |
74,399 | 74,456 | 72,617 | 68,848 | 71,725 |
Diluted EPS after Extraordinary Items |
0.56 | 1.02 | -0.23 | -0.19 | 0.78 |
Discont. Operations Per Share |
NA | 0 | 0 | 0 | 0 |
Continued operations EPS |
NA | 1.09 | -0.25 | -0.19 | 0.82 |
*Figures in thousands of U.S. Dollars except shares outstanding.
